Lupin Stock Analysis: Unveiling Opportunities in the Pharma Giant
News Pharma major Lupin has announced a strategic acquisition of the Huminsulin brand in India from Eli Lilly. This move aims to enhance Lupin's diabetes portfolio significantly. Huminsulin, a vital…